Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [F]SiTATE.
作者信息
Unterrainer Marcus, Kunte Sophie C, Unterrainer Lena M, Holzgreve Adrien, Delker Astrid, Lindner Simon, Beyer Leonie, Brendel Matthias, Kunz Wolfgang G, Winkelmann Michael, Cyran Clemens C, Ricke Jens, Jurkschat Klaus, Wängler Carmen, Wängler Björn, Schirrmacher Ralf, Belka Claus, Niyazi Maximilian, Tonn Joerg-Christian, Bartenstein Peter, Albert Nathalie L
机构信息
Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
出版信息
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4115. doi: 10.1007/s00259-023-06409-8.
Abstract
摘要
相似文献
1
Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [F]SiTATE.更正：脑膜瘤的下一代PET/CT成像——使用新型SSTR靶向肽[F]SiTATE的首次临床经验
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4115. doi: 10.1007/s00259-023-06409-8.
2
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [F]SiTATE.新型 SSTR 靶向肽 [F]SiTATE 在脑膜瘤中的下一代 PET/CT 成像：初步临床经验。
Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3390-3399. doi: 10.1007/s00259-023-06315-z. Epub 2023 Jun 26.
3
PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE.正电子发射断层扫描成像脑膜瘤使用新型 SSTR 靶向肽 18F-SiTATE。
Clin Nucl Med. 2021 Aug 1;46(8):667-668. doi: 10.1097/RLU.0000000000003607.
4
Automated production of [F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumors.在 Scintomics GRP™ 平台上自动化生产 [F]SiTATE，用于神经内分泌肿瘤的 PET/CT 成像。
Nucl Med Biol. 2020 Sep-Oct;88-89:86-95. doi: 10.1016/j.nucmedbio.2020.07.008. Epub 2020 Jul 30.
5
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [F]SiTATE.使用[F]SiTATE成像的接受和未接受生长抑素类似物治疗的神经内分泌肿瘤患者生长抑素受体表达的比较
Front Oncol. 2023 Jan 30;13:992316. doi: 10.3389/fonc.2023.992316. eCollection 2023.
6
Lenticulostriatal Ischemia Shows Relevant SSTR Expression on PET/CT Imaging Using the Novel SSTR-Targeting Peptide 18 F-SiTATE.使用新型 SSTR 靶向肽 18 F-SiTATE 的 PET/CT 成像显示纹状体缺血相关 SSTR 表达。
Clin Nucl Med. 2024 Dec 1;49(12):e689-e690. doi: 10.1097/RLU.0000000000005482. Epub 2024 Oct 2.
7
Dosimetry and optimal scan time of [F]SiTATE-PET/CT in patients with neuroendocrine tumours.[F]SiTATE-PET/CT 剂量学及在神经内分泌肿瘤患者中的最佳扫描时间。
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3571-3581. doi: 10.1007/s00259-021-05351-x. Epub 2021 Apr 29.
8
Advances in PET imaging for meningioma patients.脑膜瘤患者PET成像的进展。
Neurooncol Adv. 2023 Jun 3;5(Suppl 1):i84-i93. doi: 10.1093/noajnl/vdac113. eCollection 2023 May.
9
Multimodal approach to detect osseous involvement in meningioma: additional value of (18)F-fluoride PET/CT for conventional imaging.多模态方法检测脑膜瘤的骨累及：（18）F-氟代脱氧葡萄糖 PET/CT 对常规成像的附加价值。
Radiology. 2014 Nov;273(2):521-8. doi: 10.1148/radiol.14132118. Epub 2014 Jul 25.
10
Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [F]SiTATE PET.SiTATE良好的生长抑素受体（SSTR）亚型选择性：临床[F]SiTATE正电子发射断层显像（PET）的新动力。
EJNMMI Radiopharm Chem. 2022 Sep 5;7(1):22. doi: 10.1186/s41181-022-00176-x.
引用本文的文献
1
From FDG and beyond: the evolving potential of nuclear medicine.从氟代脱氧葡萄糖（FDG）及其他方面：核医学不断发展的潜力
Ann Nucl Med. 2023 Nov;37(11):583-595. doi: 10.1007/s12149-023-01865-6. Epub 2023 Sep 25.
Zotero 插件